Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 16.52B | € 16.51B | € 14.04B | € 13.43B | € 11.59B |
Total Assets | € 39.63B | € 39.99B | € 36.74B | € 35.36B | € 32.78B |
Total Debt | € 15.56B | € 15.05B | € 14.43B | € 13.59B | € 12.84B |
Net Debt | € -967.00M | € -1.46B | € 395.00M | € 166.00M | € 1.25B |
Total Liabilities | € 21.36B | € 20.12B | € 18.40B | € 17.48B | € 16.17B |
Stockholders Equity | € 18.22B | € 19.81B | € 18.27B | € 17.77B | € 16.49B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |